| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Human CPP concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Human CPP. During the reaction, Human CPP in the sample or standard competes with a fixed amount of Human CPP on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Human CPP. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Human CPP in tested samples can be calculated by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 18.75 pg/mL |
|---|---|
| Detection Range | 31.25-2000 pg/mL |
| Total Assay Time | 2 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Human |
| Detection Method | Competitive |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Human CPP in samples.No significant cross-reactivity or interference between Human CPP and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 18.75 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 2 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Competitive ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant CPP standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy (2024) Cancers. 10.3390/cancers16020385
Heterogeneity of emotional responses to interpersonal stress in borderline personality disorder (2025) JOURNAL OF AFFECTIVE DISORDERS. 10.1016/j.jad.2025.120991
The relationship between arginine vasopressin gene polymorphisms and plasma copeptin and hypertensive disorders of pregnancy: a nested case-control study (2023) JOURNAL OF HYPERTENSION. 10.1097/HJH.0000000000003376
Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics (2024) Biomolecules. 10.3390/biom14111410
[OP.1A.03] COPEPTIN LEVELS IN PATIENTS WITH TREATMENT RESISTANT HYPERTENSION BEFORE AND AFTER RENAL DENERVATION (2017) JOURNAL OF HYPERTENSION. 10.1097/01.hjh.0000522977.62696.64
[OP.1A.02] INNATE IMMUNITY AND CARDIO-RENAL RISK IN STAGE 2-5 CKD PATIENTS (2017) JOURNAL OF HYPERTENSION. 10.1097/01.hjh.0000522976.62696.2d
[OP.1A.01] MORE CARDIOVASCULAR EVENTS AMONG WOMEN WITH UTERINE FIBROIDS: DATA OF 11,858 WOMEN FROM THE MULTI-ETHNIC NHANES SURVEY (2017) JOURNAL OF HYPERTENSION. 10.1097/01.hjh.0000522975.55072.29
The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy (2022) Diagnostics. 10.3390/diagnostics12061435
Food intake, plasma copeptin and and cardiovascular risk in patients with type 2 diabetes: a cross-sectional analysis (2024) NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. 10.1016/j.numecd.2024.01.034
Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus (2021) Diagnostics. 10.3390/diagnostics11091577
Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis (2019) MEDIATORS OF INFLAMMATION. 10.1155/2019/1939740
The levels of adropin and its therapeutic potential in diabetes (2025) JOURNAL OF ENDOCRINOLOGY. 10.1530/JOE-24-0117
Improvements in Insulin Resistance and Glucose Metabolism Related to Breastfeeding Are Not Mediated by Subclinical Inflammation (2024) Metabolites. 10.3390/metabo14110608
Copeptin and stress-induced hyperglycemia in critically ill patients: A prospective study (2021) PLoS One. 10.1371/journal.pone.0250035
Copeptin in obese and nonobese pregnant women (2024) ENDOCRINE. 10.1007/s12020-024-03957-3
Association of serum copeptin levels with pulmonary complications and heart right ventricular functions in common variable immunodeficiency (2025) BMC IMMUNOLOGY. 10.1186/s12865-025-00743-2
Acute effects of salt on blood pressure are mediated by serum osmolality (2018) Journal of Clinical Hypertension. 10.1111/jch.13374
Predictive Value of NT-proBNP, FGF21, Galectin-3 and Copeptin in Advanced Heart Failure in Patients with Preserved and Mildly Reduced Ejection Fraction and Type 2 Diabetes Mellitus (2024) Medicina-Lithuania. 10.3390/medicina60111841
Association of copeptin levels in the postpartum period with gestational diabetes (2025) Archives of Endocrinology Metabolism. 10.20945/2359-4292-2025-0053
Is there an association between sarcoidosis and atherosclerosis? (2020) INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING. 10.1007/s10554-020-02041-x
Clinical use of copeptin in migraine patients admitted to the emergency department (2020) AMERICAN JOURNAL OF EMERGENCY MEDICINE. 10.1016/j.ajem.2020.05.009
Prognostic role of serum copeptin levels in adults with graded traumatic brain injury (2024) IRISH JOURNAL OF MEDICAL SCIENCE. 10.1007/s11845-024-03818-y
Serum copeptin as a biomarker of hypertension in children with obesity (2022) PEDIATRICS INTERNATIONAL. 10.1111/ped.15355
Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents? (2020) JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM. 10.1515/jpem-2020-0240
Serum copeptin level can be a helpful biomarker in evaluation of myocardial perfusion scintigraphy results (2016) Cardiology Journal. 10.5603/CJ.a2015.0036
